At least in part, the deterioration in glucose tolerance in OR mice treated with the anti-LIF antibody was due to the development of insulin resistance, as determined by an insulin-tolerance test (Fig. 7c) and the determination of the constant for glucose decay during the insulin tolerance test (kITT) (Fig. 7d). The gene discussed is LIF; the disease is Insulin resistance.